Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membrane anionic phospholipids and cell wall surface anions represent a critical class of therapeutic targets primarily utilized by cationic antimicrobial peptides and lipopeptides. In bacteria, these include phospholipids such as phosphatidylglycerol and cardiolipin, as well as surface-exposed molecules like lipopolysaccharides in Gram-negative bacteria and teichoic acids in Gram-positive bacteria. These molecules impart a net negative charge to the microbial surface, which facilitates the selective recruitment of positively charged antimicrobial agents through electrostatic attraction. Once bound, these drugs typically disrupt the structural integrity of the membrane or cell wall, leading to rapid depolarization, leakage of essential ions, and eventual cell lysis. Because mammalian cell membranes are predominantly composed of neutral zwitterionic lipids and cholesterol, these anionic microbial components provide a basis for selective toxicity. However, pathogens can evolve resistance by modifying these anionic targets, such as by adding positively charged groups like L-lysine or D-alanine to reduce the overall negative surface charge. Understanding the spatial distribution and chemical nature of these anions is essential for developing next-generation antibiotics capable of overcoming multi-drug resistant infections.
Cationic antimicrobial agents bind to these anionic components via electrostatic interactions, leading to membrane displacement, pore formation, or physical disruption of the lipid bilayer, which results in cytoplasmic leakage and cell death.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane anionic phospholipids and cell wall surface anions (Anionic microbial surface components).